Kelly Chibale
@kelly_chibale
Professor at @UCT_News; Neville Isdell Chair; Founder and Director of H3D research centre; Editor-In-Chief at ACS Medicinal Chemistry Letters.
ID: 1291679729418821632
http://h3d.uct.ac.za 07-08-2020 10:17:23
1,1K Tweet
1,1K Takipçi
83 Takip Edilen
Excited to share our latest work in ACS Med Chem Lett! Dive into our research on #OneHealth and #GreenChemistry, where we envisaged developing SAHA analogues from agro-industrial waste. Thanks to all the co-authors. Check it out: pubs.acs.org/doi/abs/10.102… Maria-Laura Bolognesi Eleonora Diamanti
Guest feedback on their #ChatGPT intros :) "AI knows me better than I know myself!" - Prof Kelly Chibale "There were a few missing data points" - Dr Usma Alam "Ït made me seem bigger than muself!"" - Herbert Barasa #FromTelemedicineToAi
Science for Africa Foundation "You need to have granular data on which you can build AI models, that are predictive - but which you can rely on" Prof Kelly Chibale - Founder and Director of H3D
Science for Africa Foundation Kelly Chibale H3D "We have been able to use AI to propose tailored dosages for the African patient population..." Prof Kelly Chibale - Founder and Director of H3D
Science for Africa Foundation Kelly Chibale H3D Amref Health Africa in Kenya "We have to remember the basics that underpin successful AI rollout: ensuring access to affordable and reliable electricity, access to the internet - and more importantly, collection and sharing of granular data." Kelly Chibale
Science for Africa Foundation Kelly Chibale H3D Amref Health Africa in Kenya "Unfortunately sourcing data is one of the challenges we face in Africa. If you want to collect genomic data from populations, you have to do a lot of community engagement. We have a trust deficit - and for good reason!" Prof Kelly Chibale from H3D
Just published in #ClinPharmacolTher, Mwila Mulubwa and Kelly Chibale provide perspectives on model-informed approaches for optimising therapeutics in African patient populations due to genetic differences and potential pathogen-mediated metabolism 🦠 ascpt.onlinelibrary.wiley.com/doi/10.1002/cp…
Meet the #MedChemLett Early Career Board! These early-career scientists joined in January to help advocate for and shape the growth of the journal. Andrew Riley Chiara Borsari Mark Farrell John Woodland Read more ➡ go.acs.org/az5
In this #ACSMedChemLett, Borba et al. report a multistage ML-QSAR model to predict the efficacy of compounds against multiple life cycle stages of Plasmodium parasites, followed by experimental evaluation and explainable AI analysis ACS Publications Bio & Med Chem Content pubs.acs.org/doi/10.1021/ac…
#DYK we can harness #AI to improve drug development, patient matching & health monitoring? Discover how this tech is shaping the future of pharma & overcoming industry challenges in this article by The Medicine Maker bit.ly/3VOvxqE
A leading researcher in infectious disease drug discovery, particularly malaria and tuberculosis, and founder of Africa’s first integrated drug discovery platform, H3D, Prof Kelly Chibale has achieved an National Research Foundation of South Africa A-rating for his significant contributions to global health.
By evaluating their inhibitory activities against both West Nile and Zika viruses, Kennelly et al. advance the development of 3′-deoxy-3′,4′-didehydro nucleosides as promising compounds for broad-spectrum antiviral agents ACS Publications Bio & Med Chem Content #ACSMedChemLett pubs.acs.org/doi/10.1021/ac…
Meet the #MedChemLett Early Career Board! These early-career scientists joined in January to help advocate for and shape the growth of the journal. Andrew Riley Chiara Borsari Mark Farrell John Woodland Read more ➡ go.acs.org/aGV
